Navigation Links
Abbott Releases 2007 Global Citizenship Report Highlighting Strong Commitment to Access to Health Care
Date:6/2/2008

Company's Report Entitled, 'Ingenuity at Work,' Discusses Abbott's Contributions to Access, Innovation, Science Education and the Environment

ABBOTT PARK, Ill., June 2 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today released its 2007 Global Citizenship Report, "Ingenuity at Work," which is available online at http://www.abbott.com/citizenship. The report highlights Abbott's commitment to access to care, innovation, science education and the environment.

Named to the Dow Jones Sustainability World and North American Indices in 2007 for the third consecutive year, Abbott remains a leader in economic, social and environmental performance -- with the company and the Abbott Fund contributing more than $385 million in grants and products to help improve the lives of millions of people around the world.

"To us, citizenship challenges are core business challenges -- they're part of how we effectively develop, manufacture and market a product," said Miles D. White, chairman and chief executive officer, Abbott. "We view citizenship as a matter of competitiveness and business discipline. We find it invigorating that society is demanding more of business enterprises today, and we're energized to meet and extend these new standards."
Following are some of Abbott's major accomplishments in 2007:

Access to Care

-- Provided support and resources to clinics and laboratories in Africa to

help people in need access medical care and supplies. Abbott plans to

help modernize 23 additional laboratories in Africa in 2010.

-- Offered more than $183 million worth of free Abbott medicines,

nutritionals and medical devices through patient assistance programs

worldwide.

Innovation

-- Invested more than $2.5 billion in research and development, an

increase of 11.1 percent from the previous year. Through medical

advancements and new scientific technologies, Abbott is tackling some

of today's most pressing chronic diseases -- diabetes, cancer and

cardiovascular disease.

-- Introduced the first and only co-formulated protease inhibitor tablet

suitable for children with HIV. The tablet does not require

refrigeration and does not need to be taken with food -- two important

advances in delivering HIV medicine. Kaletra (known as Aluvia in

developing countries) was filed or has been approved in 156 developed

and developing countries.

Science Education

-- Supported science education in the United States through a new program

called "Labs Are Vital," which helps to raise awareness of the

life-saving work clinical laboratory professionals provide in improving

health outcomes.

-- Launched pilot programs to enhance science education and worked closely

with teachers in several U.S. cities to promote science in the

classrooms. In 2008, Abbott aims to expand these programs across the

country.

Environment

-- Became the first FORTUNE 500 company to go "carbon neutral" with its

fleet of sales vehicles.

-- Improved operations to help protect the environment, including reducing

carbon dioxide (CO2) emissions with plans to reduce total emissions by

30 percent by 2011.

-- Continued to work towards 2010 goals to reduce water usage, waste,

employee injuries and commercial vehicle fleet accidents to help

generate the greatest environmental, health and safety benefits.

About Abbott's 2007 Global Citizenship Report

Abbott's full 2007 report is now available online at http://www.abbott.com/citizenship, including a copy of the company's Global Reporting Initiative (GRI) Index. In order to reduce its environmental impact, the company published a shortened version of the print report and expanded the information available on its Web site. The abbreviated print version can be downloaded from the Web site or requested by email at globalcitizenship@abbott.com.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 68,000 people and markets its products in more than 130 countries. Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.


'/>"/>
SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Abbott to Present at Bear Stearns Healthcare Conference
2. The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events
3. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
4. Abbott Declares 335th Consecutive Quarterly Dividend
5. Abbott Again Honored as Top Company for Working Moms
6. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
7. Abbott Hosts Conference Call for Third-Quarter Earnings
8. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
9. Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine
10. Abbott Again Honored as a Leader in Diversity
11. Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... ... at Reproductive Medicine Associates of Connecticut (RMACT) have earned “Top Doctor” awards. Dr. ... Dr. Shaun Williams have each been chosen by their peers for the 2017 ...
(Date:1/19/2017)... Diego, CA (PRWEB) , ... January 19, 2017 , ... ... their 2017 collaboration with the American Heart Association; “Howe” Healthy is Your Heart ... to stay healthy and active. Each year, Bill Howe Plumbing, Heating & Air receives ...
(Date:1/19/2017)... ... 19, 2017 , ... The 21st Century Cures Act’s Impact on Medical Devices:, ... 2016 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/21stcenturycures          , ... to thrive this year? , The passage of the act means devicemakers will be ...
(Date:1/19/2017)... Aliso Viejo, California (PRWEB) , ... January 19, ... ... self animating paragraph styled text designs that will simplify the editing process for ... , ProParagraph Basics is a package of 30 simplistically styled self-animating paragraphs ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... Breast Surgery Symposium, a conference where hundreds of surgeons from over fifteen different ... Covering topics from cosmetic breast augmentation to breast reconstruction for breast ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... 18, 2017   Regenicin, Inc. (OTC Bulletin ... in the development and commercialization of regenerative cell therapies ... recently reported the Company,s operating results for 2016 and ... As the Company described in its recent 10-K filing ... substantial accomplishments. The Company,s contract laboratory completed its evaluation ...
(Date:1/18/2017)... 18, 2017  Dermata Therapeutics, LLC, a biotechnology ... a variety of dermatological diseases, announces dosing the ... a Phase 2 acne rosacea study. DMT210 is ... proinflammatory cytokines in the skin responsible for the ... This clinical trial, DMT210-003, is a ...
(Date:1/18/2017)... , Jan. 18, 2017 Safe Rx ... of pharmacies based in Loveland, Colorado ... Vials (LPVs) in selected Good Day locations.     ... a cost-effective alternative for secure storage," said Milton ... less than the price of a cup of coffee, ...
Breaking Medicine Technology: